May 28, 2026 | Press ReleasesCollaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic’s C1 Platform Capabilities for Fast, Scalable Biologic ProductionJUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE)...

SARASOTA, Fla., April 9, 2026 /PRNewswire/ -- Ziptek, an emerging international medical device innovator, today announced significant clinical and commercial momentum for its revolutionary ZipE® Biolock™ technology—a first-of-its-kind, resorbable tissue...

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)Mar 4, 2026 | Press ReleasesJUPITER, Fla. and BENGALURU, India, March 04, 2026 (GLOBE NEWSWIRE) —...

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development MilestoneJUPITER, Fla. and COPENHAGEN, Denmark, March 02, 2026 (GLOBE NEWSWIRE) — Dyadic...

February 24, 2026 08:30 ET | Source: Cadrenal Therapeutics Inc.Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no...

CONTEMPORARY HEALTH SYSTEMS Announces the USPTO has issued a Patent for its Biomarker Assessment of Olfactory and Gustatory Functioning for Detection andMonitoring of multiple neurological diseases and downstream medical conditionsWEST...

HUNTSVILLE (October 30, 2025) – Scientists at Score Pharma, a therapeutics company located on the HudsonAlpha Institute for Biotechnology campus, believe they’ve found a way to make existing antibodytherapies for...

Advances knowledge about the use of tecarfarin in patients with severe kidney impairment, including dialysisPivotal step forward in pursuit of ESKD + Atrial Fibrillation (AFib) registration trialAddresses a critical current...

A landmark study in Advanced Science details what is believed to be the first digital twin derived from an organ-on-a-chip, combining multi-organ biology with PK/PD modeling to predict human drug...

(NAPLES, Florida - July 16, 2025) — Arthrex, a global leader in minimally invasive surgical technology, announced that it has received U.S. Food and Drug Administration (FDA) clearance to use...